Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

NCT02114931 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
467
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen